$SGNT Sagent Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in Sagent Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sagent Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Sagent Pharmaceuticals, Inc. for free.
CIK Number: 0001369786
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SGNT
Company Address: 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG 60195
Phone number: 847-908-1604
Former name: NHS PHARMACEUTICALS, date of change: 2006-07-20
Former name: Sagent Holding Co., date of change: 2009-05-29
Prev close: $0.00
Average Daily Volume: 889,241
Days Low: $0.00
Year Low: $10.55
Year High: $21.88
Sagent Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | U | 21.75 | 34,961 | 760,402 | 0 | 35 K to 0 (-100.00 %) |
Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | U | 21.75 | 2,978,803 | 64,788,965 | 0 | 3 M to 0 (-100.00 %) |
Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 13.55 | 17 | 230 | 25,320 | 25.3 K to 25.3 K (-0.07 %) |
Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 13.55 | 2,299 | 31,151 | 3,456,332 | 3.5 M to 3.5 M (-0.07 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 20.10 | 55,000 | 1,105,500 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 16.45 | 12,067 | 198,502 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 20.16 | 10,638 | 214,462 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 14.61 | 34,783 | 508,180 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Sell | D | 21.75 | 27,206 | 591,731 | 0 | 27.2 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Sell | U | 21.75 | 7,857 | 170,890 | 27,206 | 35.1 K to 27.2 K (-22.41 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Sell | D | 21.75 | 3,665 | 79,714 | 35,063 | 38.7 K to 35.1 K (-9.46 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Option Exercise | D | 14.61 | 108,696 | 1,588,049 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Sell | D | 21.75 | 92,527 | 2,012,462 | 0 | 92.5 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Sell | D | 21.75 | 9,459 | 205,733 | 92,527 | 102 K to 92.5 K (-9.27 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 11.60 | 6,379 | 73,996 | 0 |